Biotech

All Articles

Former Seagen CEO unveils new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually sold to Pfizer in 2015 for a m...

Ironwood produces more bid for $1B GI drug with brand-new subgroup data

.On the heels of a period 3 succeed that fell short to wow entrepreneurs, Ironwood Pharmaceuticals i...

Novartis inks $150M offer for autoimmune molecular adhesive

.Do not stop Monte Rosa Therapeutics currently. The Boston-based biotech is enjoying after authorizi...

Jade takes officer staff with Chinook vets-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and a...

Septerna goes public with upsized offering of $288M

.Celebrating his provider's upsized initial public offering (IPO), Septerna chief executive officer ...

AbbVie brings in Richter richer, paying out $25M to constitute discovery pact

.AbbVie has actually gone back to the source of its antipsychotic goliath Vraylar looking for anothe...

GenSight goes into last full weeks of cash path as profits stream edges out of grasp

.GenSight Biologics is weeks off of running out of money. Once again. The biotech only has enough ca...

AZ licenses thrown out rare disease drug to Monopar Rehabs

.Monopar Therapies is recovering a medication coming from the scrap heap of AstraZeneca's rare ailme...

Arcus' brand-new HIF-2a records in kidney cancer mean potential advantage over Merck's Welireg, analysts point out

.Along with brand-new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of pro...

Roche bets approximately $1B to broaden Dyno gene treatment shipping contract

.After creating a genetics therapy alliance along with Dyno Therapeutics in 2020, Roche is back for ...